NO20015772L - Forbindelser og fremgangsmåter for behandling av post- traumatisk stress-syndrom - Google Patents

Forbindelser og fremgangsmåter for behandling av post- traumatisk stress-syndrom

Info

Publication number
NO20015772L
NO20015772L NO20015772A NO20015772A NO20015772L NO 20015772 L NO20015772 L NO 20015772L NO 20015772 A NO20015772 A NO 20015772A NO 20015772 A NO20015772 A NO 20015772A NO 20015772 L NO20015772 L NO 20015772L
Authority
NO
Norway
Prior art keywords
post
compounds
treatment
methods
traumatic stress
Prior art date
Application number
NO20015772A
Other languages
English (en)
Other versions
NO20015772D0 (no
Inventor
Jeffrey Berlant
Original Assignee
Jeffrey Berlant
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jeffrey Berlant filed Critical Jeffrey Berlant
Publication of NO20015772D0 publication Critical patent/NO20015772D0/no
Publication of NO20015772L publication Critical patent/NO20015772L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20015772A 1999-05-28 2001-11-27 Forbindelser og fremgangsmåter for behandling av post- traumatisk stress-syndrom NO20015772L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13644999P 1999-05-28 1999-05-28
PCT/US2000/014593 WO2000072841A1 (en) 1999-05-28 2000-05-26 Compounds and methods for the treatment of post traumatic stress disorder

Publications (2)

Publication Number Publication Date
NO20015772D0 NO20015772D0 (no) 2001-11-27
NO20015772L true NO20015772L (no) 2002-01-22

Family

ID=22472908

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015772A NO20015772L (no) 1999-05-28 2001-11-27 Forbindelser og fremgangsmåter for behandling av post- traumatisk stress-syndrom

Country Status (8)

Country Link
US (1) US6486198B1 (no)
EP (1) EP1187604A4 (no)
JP (1) JP2003500444A (no)
AU (1) AU768393B2 (no)
CA (1) CA2374175A1 (no)
MX (1) MXPA01012187A (no)
NO (1) NO20015772L (no)
WO (1) WO2000072841A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420369B1 (en) * 1999-05-24 2002-07-16 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating dementia
CA2459146A1 (en) * 2001-08-30 2003-03-13 Ortho-Mcneil Pharmaceutical, Inc. Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors
US20030224006A1 (en) 2002-03-01 2003-12-04 Zaworotko Michael J. Multiple-component solid phases containing at least one active pharmaceutical ingredient
US6559293B1 (en) 2002-02-15 2003-05-06 Transform Pharmaceuticals, Inc. Topiramate sodium trihydrate
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US7790905B2 (en) 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US20040266776A1 (en) * 2003-06-25 2004-12-30 Gil Daniel W. Methods of preventing and reducing the severity of stress-associated conditions
EP1515703A1 (en) 2002-06-21 2005-03-23 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
US20040115262A1 (en) * 2002-07-29 2004-06-17 Frank Jao Formulations and dosage forms for controlled delivery of topiramate
AR039744A1 (es) * 2002-06-26 2005-03-09 Alza Corp Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
WO2004082517A2 (en) * 2003-03-19 2004-09-30 Bar Ilan University Animal exhibiting ptsd-like behavior, per pct rule 4.3
GB0325175D0 (en) * 2003-10-28 2003-12-03 Novartis Ag Organic compounds
AU2004308973A1 (en) * 2003-12-23 2005-07-14 Alza Corporation Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US5384327A (en) * 1992-12-22 1995-01-24 Mcneilab, Inc. Anticonvulsant sorbopyranose sulfamates
US5498629A (en) * 1993-12-23 1996-03-12 Ortho Pharmaceutical Corporation Anticonvulsant pseudofructopyranose sulfamates
US6472370B1 (en) * 1998-11-17 2002-10-29 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating post traumatic stress disorder

Also Published As

Publication number Publication date
US6486198B1 (en) 2002-11-26
NO20015772D0 (no) 2001-11-27
WO2000072841A1 (en) 2000-12-07
EP1187604A1 (en) 2002-03-20
AU768393B2 (en) 2003-12-11
CA2374175A1 (en) 2000-12-07
MXPA01012187A (es) 2002-06-21
EP1187604A4 (en) 2004-02-11
AU5296300A (en) 2000-12-18
JP2003500444A (ja) 2003-01-07

Similar Documents

Publication Publication Date Title
NO994778L (no) Fremgangsmåter og preparater for behandling av inflammatorisk tarmsyndrom
ATE376994T1 (de) Adamantanderivate zur behandlung von entzündlichen, immunologischen und kardiovaskulären erkrankungen
NO20040873L (no) Fremgangsmate og anordning for sammensetting av gjenfestbare absorberende klesplagg
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
NO20015542L (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO20022087L (no) Fremgangsmåte for behandling av diabetes
FI20000863A (fi) Uusi hoitomenetelmä
NO985484L (no) FremgangsmÕte og preparat for behandling og forhindring av hyperurikemi
EA200500098A1 (ru) Лекарственное средство и способ лечения патологического синдрома
NO20015772L (no) Forbindelser og fremgangsmåter for behandling av post- traumatisk stress-syndrom
NO20014314D0 (no) Blandinger og metoder for behandling av stafylokokkisk infeksjon
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20041004L (no) Fremgangsmate og anordning for sammensetting av gjenfestbare absorberende klesplagg
NO20012963L (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO20023482D0 (no) Fremgangsmåte for behandling av stoffmisbruk
NO20033498L (no) Fremgangsmåte for behandling og törking av trevirke
NO20010464D0 (no) Fremgangsmåter og sammensetninger for behandling av gastroösofrageal-reflukssyndrom
NO20024776L (no) Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
NO20020784D0 (no) Medikament for behandling av brudd
NO20023737L (no) Fremgangsmåte og preparater for behandling av en inflammatorisk lidelse
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
NO20013651D0 (no) Anvendelse av fosfororganiske forbindelser for profylaktisk og terapeutisk behandling av infeksjoner
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
NO20022990D0 (no) Fremgangsmåte og sammensetning for behandling av smerte

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application